{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:55:34Z","timestamp":1759341334655},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1006\/gyno.2001.6482","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:48:37Z","timestamp":1033933717000},"page":"140-144","source":"Crossref","is-referenced-by-count":38,"title":["Trimetrexate in the Treatment of Recurrent or Advanced Leiomyosarcoma of the Uterus: A Phase II Study of the Gynecologic Oncology Group"],"prefix":"10.1006","volume":"84","author":[{"given":"Harriet O.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Blessing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Vaccarello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/gyno.2001.6482_RF1","first-page":"399","article-title":"The epidemiology of sarcomas of the uterus","volume":"76","author":"Harlow","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"10.1006\/gyno.2001.6482_RF2","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/j.1471-0528.1992.tb13827.x","article-title":"Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors: the result of a retrospective study of 423 cases of uterine sarcoma","volume":"99","author":"Olah","year":"1992","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1006\/gyno.2001.6482_RF3","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/1097-0142(19950101)75:1+<270::AID-CNCR2820751312>3.0.CO;2-D","article-title":"Female genital tract cancer","volume":"75","author":"Platz","year":"1995","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6482_RF4","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/cncr.2820710440","article-title":"Prognostic factors in early-stage uterine sarcoma","volume":"71","author":"Major","year":"1993","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6482_RF5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0002-9378(78)90445-3","article-title":"Endometrial sarcoma: lymphatic spread patterns","volume":"130","author":"DiSaia","year":"1978","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6482_RF6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1006\/gyno.1996.0185","article-title":"Uterine leiomyosarcoma: analysis of treatment failures and survival","volume":"62","author":"Gadduci","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6482_RF7","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/0360-3016(86)90011-8","article-title":"Observations on the use of adjuvant radiation therapy in patients with Stage I and II uterine sarcoma","volume":"12","author":"Hornback","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1006\/gyno.2001.6482_RF8","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1200\/JCO.1991.9.11.1962","article-title":"Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study","volume":"9","author":"Thigpen","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00000421-198602000-00005","article-title":"Cisplatin as second-line chemotherapy in the treatment of advanced or recurrent leiomyosarcoma of the uterus: a phase II trial of the Gynecologic Oncology Group","volume":"9","author":"Thigpen","year":"1986","journal-title":"Am J Clin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0090-8258(86)90140-X","article-title":"Cis-diamminedichloroplatin plus dimethyltriazenoimidazole carboxamide as second- and third-line chemotherapy for sarcomas of the female pelvis","volume":"23","author":"Piver","year":"1986","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6482_RF11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/0002-9378(87)90072-X","article-title":"Adjuvant therapy for stage I uterine sarcoma","volume":"156","author":"Rose","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6482_RF12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0090-8258(83)90014-8","article-title":"Treatment of advanced uterine sarcoma with adriamycin","volume":"16","author":"Hannigan","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6482_RF13","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/1097-0142(19850415)55:8<1648::AID-CNCR2820550806>3.0.CO;2-7","article-title":"Treatment of recurrent or advanced uterine sarcoma: a randomized trial of doxorubicin versus doxorubicin and cyclophosphamide (a phase III trial of the Gynecologic Oncology Group)","volume":"55","author":"Muss","year":"1985","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6482_RF14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0090-8258(83)90078-1","article-title":"Treatment of advanced uterine sarcoma with vincristine, actinomycin D, and cyclophosphamide","volume":"15","author":"Hannigan","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6482_RF15","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.1985.3.9.1240","article-title":"A randomized clinical trial of adriamycin in uterine sarcoma: a Gynecologic Oncology Group study","volume":"3","author":"Omura","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/0002-9378(92)91671-V","article-title":"Phase II trial of ifosfamide and mesna in leiomyosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"166","author":"Sutton","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6482_RF17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1006\/gyno.1996.0220","article-title":"Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study","volume":"62","author":"Sutton","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6482_RF18","first-page":"S18-30","article-title":"Folate and antifolate pharmacology","volume":"24","author":"Karmen","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF19","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/0006-2952(84)90298-3","article-title":"Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[3,4,5-(trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro","volume":"33","author":"Karmen","year":"1984","journal-title":"Biochem Pharmacol"},{"key":"10.1006\/gyno.2001.6482_RF20","first-page":"6986","article-title":"Characterization of trimetrexate transport in human lymphoblastoid cell and development of Impaired influx as a mechanism of resistance to lipophilic antifolates","volume":"48","author":"Fry","year":"1998","journal-title":"Cancer Res"},{"key":"10.1006\/gyno.2001.6482_RF21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/07357909109044227","article-title":"Update on TMTX, a folate antagonist with antineoplastic and antiprozoal properties","volume":"9","author":"Lin","year":"1991","journal-title":"Cancer Invest"},{"key":"10.1006\/gyno.2001.6482_RF22","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1084\/jem.165.3.926","article-title":"Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent","volume":"165","author":"Allegra","year":"1987","journal-title":"J Exp Med"},{"key":"10.1006\/gyno.2001.6482_RF23","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/0006-2952(79)90655-5","article-title":"2,4 Diamino-5-methyl-6-[3,4,5-(trimethoxyanilino)methyl]uinazolonine (TMQ), a potent non-classical folate antagonist inhibitor\u2014I. Effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo","volume":"28","author":"Bertino","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1006\/gyno.2001.6482_RF24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0065-2571(84)90014-1","article-title":"Biochemical pharmacology of the lipophilic antifolate, trimetrexate","volume":"22","author":"Jackson","year":"1984","journal-title":"Adv Enz Regul"},{"key":"10.1006\/gyno.2001.6482_RF25","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood.V85.10.2675.bloodjournal85102675","article-title":"Selective treatment of SCID mice bearing methotrexate-transport-resistant human acute lymphoblastic leukemia tumors with trimetrexate and leucovorin protection","volume":"85","author":"Lacerda","year":"1995","journal-title":"Blood"},{"key":"10.1006\/gyno.2001.6482_RF26","first-page":"S18-71","article-title":"Trimetrexate: experience with solid tumor","volume":"24","author":"Haller","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1200\/JCO.1997.15.3.915","article-title":"Phase II study of trimetrexate, fluorouracil, and leucovorin for advanced colorectal cancer","volume":"15","author":"Blanke","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF28","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mpo.2950210409","article-title":"Phase I trial of trimetrexate in pediatric solid tumors: a Pediatric Oncology Group study","volume":"21","author":"Pappo","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"10.1006\/gyno.2001.6482_RF29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/1097-0142(19900701)66:1<35::AID-CNCR2820660108>3.0.CO;2-V","article-title":"Treatment of uterine sarcomas","volume":"66","author":"Echt","year":"1990","journal-title":"Cancer"},{"key":"10.1006\/gyno.2001.6482_RF30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/oxfordjournals.annonc.a058051","article-title":"Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group","volume":"2","author":"Eisenhauer","year":"1991","journal-title":"Ann Oncol"},{"key":"10.1006\/gyno.2001.6482_RF31","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000291889","article-title":"Radiotherapy in the treatment of uterine sarcomas: a retrospective analysis of 54 cases","volume":"42","author":"Hoffman","year":"1996","journal-title":"Gynecol Oncol Invest"},{"key":"10.1006\/gyno.2001.6482_RF32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0090-8258(85)90209-4","article-title":"Radiotherapy and\/or chemotherapy as adjuvant treatment of uterine sarcomas","volume":"20","author":"Sorbe","year":"1985","journal-title":"Gynecol Oncol"},{"key":"10.1006\/gyno.2001.6482_RF33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0003-4975(10)62280-1","article-title":"Surgery for pulmonary metastasis: 20 year experience","volume":"38","author":"Mountain","year":"1984","journal-title":"Ann Thorac Surg"},{"key":"10.1006\/gyno.2001.6482_RF34","first-page":"173","article-title":"Uterine endolymphatic stromal myosis: a collaborative study","volume":"64","author":"Piver","year":"1984","journal-title":"Obstet Gynecol"},{"key":"10.1006\/gyno.2001.6482_RF35","first-page":"1303","article-title":"Phase II trial of etoposide in the management of advanced or recurrent leiomyosarcoma of the uterus: a Gynecologic Oncology Group study","volume":"71","author":"Slayton","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.1006\/gyno.2001.6482_RF36","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/00000421-199002000-00009","article-title":"Mitoxantrone in the treatment of advanced uterine sarcoma","volume":"13","author":"Muss","year":"1990","journal-title":"Am J Clin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF00175091","article-title":"A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus (a Gynecologic Oncology Group study)","volume":"9","author":"Slayton","year":"1991","journal-title":"Invest N Drugs"},{"key":"10.1006\/gyno.2001.6482_RF38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000421-199510000-00007","article-title":"Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus: a Gynecologic Oncology Group study","volume":"18","author":"Asbury","year":"1995","journal-title":"Am J Clin Oncol"},{"key":"10.1006\/gyno.2001.6482_RF39","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1200\/JCO.1989.7.9.1208","article-title":"Response to mesna, doxorubicin, ifosfamide and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy","volume":"7","author":"Elias","year":"1989","journal-title":"J Clin Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801964820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825801964820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T21:09:56Z","timestamp":1682284196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825801964820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S0090825801964820"],"URL":"https:\/\/doi.org\/10.1006\/gyno.2001.6482","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}